The Modified Shields Classification and 12 Families with Defined <i>DSPP</i> Mutations

Mutations in Dentin Sialophosphoprotein (<i>DSPP</i>) are known to cause, in order of increasing severity, dentin dysplasia type-II (DD-II), dentinogenesis imperfecta type-II (DGI-II), and dentinogenesis imperfecta type-III (DGI-III). <i>DSPP</i> mutations fall into two group...

Full description

Bibliographic Details
Main Authors: James P. Simmer, Hong Zhang, Sophie J. H. Moon, Lori A-J. Donnelly, Yuan-Ling Lee, Figen Seymen, Mine Koruyucu, Hui-Chen Chan, Kevin Y. Lee, Suwei Wu, Chia-Lan Hsiang, Anthony T. P. Tsai, Rebecca L. Slayton, Melissa Morrow, Shih-Kai Wang, Edward D. Shields, Jan C.-C. Hu
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/13/5/858
Description
Summary:Mutations in Dentin Sialophosphoprotein (<i>DSPP</i>) are known to cause, in order of increasing severity, dentin dysplasia type-II (DD-II), dentinogenesis imperfecta type-II (DGI-II), and dentinogenesis imperfecta type-III (DGI-III). <i>DSPP</i> mutations fall into two groups: a 5′-group that affects protein targeting and a 3′-group that shifts translation into the −1 reading frame. Using whole-exome sequence (WES) analyses and Single Molecule Real-Time (SMRT) sequencing, we identified disease-causing <i>DSPP</i> mutations in 12 families. Three of the mutations are novel: c.53T>C/p.(Val18Ala); c.3461delG/p.(Ser1154Metfs*160); and c.3700delA/p.(Ser1234Alafs*80). We propose genetic analysis start with WES analysis of proband DNA to identify mutations in <i>COL1A1</i> and <i>COL1A2</i> causing dominant forms of osteogenesis imperfecta, 5′-<i>DSPP</i> mutations, and 3′-<i>DSPP</i> frameshifts near the margins of the <i>DSPP</i> repeat region, and SMRT sequencing when the disease-causing mutation is not identified. After reviewing the literature and incorporating new information showing distinct differences in the cell pathology observed between knockin mice with 5′-<i>Dspp</i> or 3′-<i>Dspp</i> mutations, we propose a modified Shields Classification based upon the causative mutation rather than phenotypic severity such that patients identified with 5′-<i>DSPP</i> defects be diagnosed as DGI-III, while those with 3′-<i>DSPP</i> defects be diagnosed as DGI-II.
ISSN:2073-4425